PKvitality is a Paris-based bio-wearable startup founded in 2017 developing K’Watch, a painless smartwatch continuous glucose monitoring (CGM) device. K’Watch uses a consumable called K’apsul and SkinTaste technology—an array of biochemical sensors with micro‑points that contact interstitial fluid in the upper skin layer to measure glucose without blood. The company is also developing K’Watch Athlete to provide real‑time lactic acid monitoring for athletes. PKvitality reports strong preclinical results and aims to reach a First in Man milestone. It secured €2.25 million from an agreement with Beurer GmbH; the funds will support continued development and validation. Beurer has acquired exclusive commercialisation rights for Germany, Austria and Italian tenders and agreed a sales volume that will significantly contribute to PKvitality’s commercial volume.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2020